Page last updated: 2024-08-21

malondialdehyde and Leukemia, Myeloid, Acute

malondialdehyde has been researched along with Leukemia, Myeloid, Acute in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdulkadyrov, KM; Gritsaev, SV; Kapustin, SI; Rybakova, LP; Sergeev, AN; Shikhbabaeva, DI1
Esfahani, A; Ghorbanihaghjo, A; Ghoreishi, Z; Nikanfar, A; Sanaat, Z1
Fisher, LJ; Greenberg, M; Lau, R; Lehotay, DC; Luo, X; Yazdanpanah, M1
Brajtburg, J; Medoff, G; Vertut-Croquin, A1

Other Studies

4 other study(ies) available for malondialdehyde and Leukemia, Myeloid, Acute

ArticleYear
[Time course of changes in iron metabolic and oxidative-antioxidative system parameters in patients with acute myeloid leukemia].
    Terapevticheskii arkhiv, 2013, Volume: 85, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Catalase; Ceruloplasmin; Female; Free Radicals; Humans; Iron; Leukemia, Myeloid, Acute; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Transferrin; Treatment Outcome

2013
Influence of chemotherapy on the lipid peroxidation and antioxidant status in patients with acute myeloid leukemia.
    Acta medica Iranica, 2012, Volume: 50, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cytarabine; Daunorubicin; Female; Glutathione Peroxidase; Humans; Leukemia, Myeloid, Acute; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase

2012
Cytotoxic aldehydes as possible markers for childhood cancer.
    Free radical biology & medicine, 1997, Volume: 23, Issue:6

    Topics: Adolescent; Aldehydes; Biomarkers, Tumor; Bone Neoplasms; Burkitt Lymphoma; Carnitine; Child; Child, Preschool; Doxorubicin; Humans; Infant; Leukemia, Myeloid, Acute; Lipid Peroxidation; Lymphoma, Large B-Cell, Diffuse; Malondialdehyde; Neoplasms

1997
Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60.
    Cancer research, 1986, Volume: 46, Issue:12 Pt 1

    Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Line; Dactinomycin; Drug Synergism; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Lomustine; Malondialdehyde; Oxidation-Reduction; Potassium; Thymidine

1986